Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and safety of low-dose versus standard-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation
2005-004102-90Phase 4Completed
- Sponsor
- Oxford University Hospitals
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amiodarone in Atrial fibrillation (AFib) (2 arms), sponsored by Oxford University Hospitals. Primary endpoint: maintenance of sinus rhythm. Started May 2007; status: completed.
02
Drugs
amiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2005-004102-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004102-90.